Loading
Solesence, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by WHITMORE R JANET, was filed 30 Dec 2025.
Solesence, Inc.: what insiders have been doing
Solesence, Inc., classified in the Food & Beverage sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (23 October 2025 to 23 October 2026), 7 filings came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 7 purchases totalling €59k, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €29k by Whitmore R Janet, published on 11 December 2025. The buyers include 1 senior executive.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 7 filings here. Over the whole record (from 2016), the tally stands at 220 purchases and 62 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 62.1 m USD and net income of 1.8 m USD.
The last insider purchase was made public on 30 December 2025, 297 days ago. Filings reach the SEC (Form 4) feed a median of 22 days after the trade. US insiders must file a Form 4 within two business days of a trade.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
367
Thresholds
n/a
Buy Volume
€60M
220 ops. · all time
Sell Volume
€30M
62 ops. · all time
Who traded when
BuySaleR. Janet Whitmore7 buys
Bradford T. Whitmore2 buys
Kevin Cureton2 sales
Since the insiders bought
- -44.2%Entry US$1.60 · Close 19 Oct 2026 US$0.89
- -69.8%Entry US$4.17 · Close at T+365 US$1.26
- +100.6%Entry US$1.65 · Close at T+365 US$3.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,427 of 26,250 companies
26.2
score / 100
Value26
Quality26
FCF yld-17%
Earn yld2.8%
EV/EBITDA23.7x
ROE-19%
Gross mgn26%
Net mgn2.9%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.89
Analyst consensus
Income statement
RevenueUS$62.1M
Gross profitUS$16.1M26% margin
EBITDAUS$3.7M6% margin
Net incomeUS$1.8M-5.3% margin
Valuation
P/Book4.8x
Beta1.38
Balance sheet & cash
Market capUS$63.1M
Total debtUS$24.3M
Free Cash Flow-US$10.7M
Debt / Equity173%
Profitability & ownership
ROE-18.6%
ROA-2.4%
% insiders73.1%
% institutions5.4%
Last declaration on 30 December 2025
Declarations367 total
1,000 shares@ US$1.920.2% of flowCommon StockSEC:0001193125-25-336020:1
Canonical exit: 24 Mar 2026 (T+90)
1,500 shares@ US$1.917.6% of flowCommon StockSEC:0001193125-25-336020:0
Canonical exit: 24 Mar 2026 (T+90)
5,000 shares@ US$1.871.0% of flowCommon StockSEC:0001193125-25-315434:1
Canonical exit: 15 Feb 2026 (T+90)
267 shares@ US$1.830.1% of flowCommon StockSEC:0001193125-25-315434:2
Canonical exit: 16 Feb 2026 (T+90)
5,000 shares@ US$1.951.1% of flowCommon StockSEC:0001193125-25-315434:3
Canonical exit: 17 Feb 2026 (T+90)
5,000 shares@ US$1.891.0% of flowCommon StockSEC:0001193125-25-315434:4
Canonical exit: 17 Feb 2026 (T+90)
19,789 shares@ US$1.7392.4% of flowCommon StockSEC:0001193125-25-315434:0
Canonical exit: 12 Feb 2026 (T+90)
4,693 shares@ US$3.962.6% of flowCommon StockSEC:0000950170-25-083345:1
38,807 shares@ US$0.422.3% of flowCommon StockSEC:0000950170-25-083345:2
38,807 shares@ US$3.8021.0% of flowCommon StockSEC:0000950170-25-083345:3
4,693 shares@ US$0.42100.0% of flowCommon StockSEC:0000950170-25-083345:0
4,189,000 shares@ US$4.2017.3% of flowCommon StockSEC:0000933430-25-000004:1
Canonical exit: 27 Aug 2025 (T+90)
2,500,000 shares@ US$4.20100.0% of flowCommon StockSEC:0000933430-25-000004:0
Canonical exit: 27 Aug 2025 (T+90)
2,000 shares@ US$1.100.3% of flowCommon StockSEC:0000950170-24-121444:4
Canonical exit: 27 Jan 2025 (T+90)
10,000 shares@ US$0.821.0% of flowCommon StockSEC:0000950170-24-121444:7
Canonical exit: 27 Jan 2025 (T+90)
6,667 shares@ US$0.450.3% of flowCommon StockSEC:0000950170-24-121444:8
Canonical exit: 27 Jan 2025 (T+90)
2,000 shares@ US$1.050.2% of flowCommon StockSEC:0000950170-24-121444:1
Canonical exit: 27 Jan 2025 (T+90)
2,000 shares@ US$1.180.3% of flowCommon StockSEC:0000950170-24-121444:2
Canonical exit: 27 Jan 2025 (T+90)
2,000 shares@ US$0.840.2% of flowCommon StockSEC:0000950170-24-121444:3
Canonical exit: 27 Jan 2025 (T+90)
2,000 shares@ US$0.990.2% of flowCommon StockSEC:0000950170-24-121444:5
Canonical exit: 27 Jan 2025 (T+90)
10,000 shares@ US$0.680.8% of flowCommon StockSEC:0000950170-24-121444:6
Canonical exit: 27 Jan 2025 (T+90)
6,666 shares@ US$1.1650.9% of flowCommon StockSEC:0000950170-24-121444:9
Canonical exit: 27 Jan 2025 (T+90)
2,000 shares@ US$0.900.8% of flowCommon StockSEC:0000950170-24-121444:0
Canonical exit: 27 Jan 2025 (T+90)
23,150 shares@ US$1.604.2% of flowCommon StockSEC:0000950170-24-109324:1
Canonical exit: 23 Dec 2024 (T+90)
200 shares@ US$1.590.0% of flowCommon StockSEC:0000950170-24-109324:2
Canonical exit: 23 Dec 2024 (T+90)
25 of 367 declarations
About Solesence, Inc.
Solesence, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions for the health and wellness sector.
